StockData
Ironwood Pharmaceuticals Inc logo

Ironwood Pharmaceuticals Inc (IRWD) stock

IRWDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3062% below fair value
$4.87+0.02 (+0.41%)

Close on Nov 17, 2026Market cap $804.72MP/E 6.3Yield –

Ironwood Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Ironwood Pharmaceuticals's market cap was $794.80M on Nov 10, 2026, against $569.38M a year earlier. Over the last 5 years it ranged from $96.94M to $2.22B, with a median of $1.09B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 10, 2026$794.80M+45.0%
2025Dec 31, 2025$548.23M-22.7%
2024Dec 31, 2024$708.87M-60.3%
2023Dec 29, 2023$1.79B-6.0%
2022Dec 30, 2022$1.90B-0.3%
2021Dec 31, 2021$1.91B+4.5%
2020Dec 31, 2020$1.82B-12.6%
2019Dec 31, 2019$2.09B+305.4%
2017Jan 31, 2017$514.78M-6.0%
2016Dec 30, 2016$547.35M-55.4%
2015Dec 31, 2015$1.23B-39.4%
2014Dec 31, 2014$2.02B+111.8%
2013Dec 31, 2013$955.32M-19.0%
2012Dec 31, 2012$1.18B-0.9%
2011Dec 30, 2011$1.19B+1515.5%
2010Dec 31, 2010$73.66M–

More Ironwood Pharmaceuticals figures

See a number that looks wrong?